{"name":"Applied Therapeutics, Inc.","slug":"applied-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":455000,"revenueGrowth":-95.4,"grossMargin":0,"rdSpend":48744000,"netIncome":-105624000,"cash":86691000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AT-007","genericName":"AT-007","slug":"at-007","indication":"Diabetic peripheral neuropathy","status":"phase_3"}]}],"pipeline":[{"name":"AT-007","genericName":"AT-007","slug":"at-007","phase":"phase_3","mechanism":"AT-007 is a small molecule that inhibits aldose reductase, the first enzyme in the polyol pathway, to reduce sorbitol accumulation and prevent diabetic complications.","indications":["Diabetic peripheral neuropathy","Galactokinase deficiency"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNVHVPcjJiLVljS3pRaEhXdlRwMWRLQlpxZFd6NFNNQmJIVW53RDljaFUwR1RXWmtpbjlLOWJUaUdaMWZ0THk1UDZHVF9EdkF1QlRzT0V4Q0htQkY4V1ZwM19hSFlNUXpUOTRfVS1aTHN2MEdBNHl1UU1HUzR3eXcyblZYNTkzTlhGNWsxcVFwN2UzanlCN3A0?oc=5","date":"2026-03-23","type":"pipeline","source":"Traders Union","summary":"Applied Therapeutics shifts social media operations to Cycle Pharmaceuticals - Traders Union","headline":"Applied Therapeutics shifts social media operations to Cycle Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNSVo2S2NrejZMeWpvQ0tGZnhDVmFmRlVfbVVQWUx2MkZ3NjdSOUtteUk5aDBFODB2X01Ja2hxYzByOVBIVTVXOGkxdVV4alRMZ0pRUFI3UlpvLU5ZMm9vZ1o2MnRrVmo5TnpsT3h2Z0x1SmJPc3pnbmRFMGFlMUE0ekh2RmpPLURZVUhyb0pueG90bkhQOTlZdmZOZUw1OG5icDNzQmQyYkU5a2V4dU5DQjlzZmhGSzFCdXZMSWNkaEUxUQ?oc=5","date":"2026-02-03","type":"pipeline","source":"Business Wire","summary":"Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics - Business Wire","headline":"Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNaEtWTnJaV01rSThxdkpsU2d5QjI1UHJrbFZFU0YySlFwSnRiU19paHBDY0tIWklpSXlxMlpKZHBrZldDVFd4b3ZwYk9XTXZ6ODg1dTJnWGF1cmlSWkR4bnhvRjJmcVd5OHdFa2JMTWFJQWoxZ2pyNUxMWmJFUFVpQkZFaXNIUnc3T3JwbzI2SFlMcFI0ZW9reFYyVzY?oc=5","date":"2026-02-03","type":"deal","source":"Contract Pharma","summary":"Cycle Group Holdings Acquires Applied Therapeutics - Contract Pharma","headline":"Cycle Group Holdings Acquires Applied Therapeutics","sentiment":"neutral"},{"date":"2026-02-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWFVRNTZqbnMyN1hnZEhEaHFDR2Nvb3Ntd20xaUppVWJkdS1nVXE4VUxVRTFkSC1WcVdsbU5RQ0gwZjZZdjlodG5XZGVSOUVYVkVHWVNNTlJSeTRLNEdlU2tNRDBpUnQ5bkZzTWI1YVBsbWVERXlXR0VWTkhaNXFpZUxNeWxVNHA0cEZ1MHIxc2ZwOGtKTW1vQXRBVQ?oc=5","date":"2026-01-30","type":"pipeline","source":"Yahoo Finance","summary":"Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer - Yahoo Finance","headline":"Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPenFqS216Ml8yWW0tTEhHSFR3dEcwbVpPWnVqcWVPQTVOaWI4VnlXVXZTakUzbHM0MnZBWVVZREV0aTE1b05KTWtqZ000cUtHVkdQZW00M0RLeGNrQWNIaF82cE5BT2ZRR1hJTzYwVGF4MUx3WVVJV21CVXJjVUZtNnhSUlFQbEVfbzF0bFc2cTN0c09jd1BONWQ4aVlZUnpXeVB2RFZpNTVnR3dPZ24xWjByeG9GV0l3X0FFMmZR?oc=5","date":"2025-12-15","type":"pipeline","source":"The Times","summary":"British drugs company Cycle Pharma snaps up US competitor - The Times","headline":"British drugs company Cycle Pharma snaps up US competitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOUTYxazZJdnBsVmExczFobVM5NWR4TGh0ZUtYUGl6dEQyb2xvRG42NnR1QnU3X3ZiWm5PcUtobkdRWGQ4aEZVUGIyRDRyX041U2duV3lzOGYtR3NTaXg3ZWowckR0RWltc3ZzMlBlSUVaM21jb1FZdUJXUC1qVHg5SWxHT21vTXExVzdOTUUwWUI0RGFOVVVSVE1HVjB1Yzk3MXFVRHNGS2dzYTFZSFE?oc=5","date":"2025-12-12","type":"pipeline","source":"Fierce Biotech","summary":"Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share - Fierce Biotech","headline":"Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNalRQM1JwcXB5dmpKbkJiTzUxQXV3V29pMjdEcHpBeEtCZlk3bnRnQm5CZnN0SU5iMHlpVV85X3JKUlR4b2lqcWJYTmsxYmQ4NUNrUWpveENRSUJUaW1hT2EzSGVNYnB1cS1rOUJwZnRqSFdBSVN6ZEIzZ1JkVDl0akd0WnptWERELThoaXZHUlB3UQ?oc=5","date":"2025-12-12","type":"deal","source":"The Pharma Letter","summary":"Cycle Pharma to acquire Applied Therapeutics - The Pharma Letter","headline":"Cycle Pharma to acquire Applied Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNY0ZSUWxiY2VVb2FHdjdManoyVHJ5NkE2N1RVQUUtU3JpUE9QcV9PcFRpNjVYWFJSbXhGRXA1aVVTeFR6cDVDOHMtR2NKZGpFaHBLN28zRldqaW91aXJKdWJXdWdPYjA4cDdKcjFraWpxTTF2OWhOZENRMkcxak51Wjl6d3daeGZfdHkxQmVJd2pjWkJiRzdQUWRBdw?oc=5","date":"2025-12-12","type":"deal","source":"BioWorld News","summary":"Cycle buying Applied Therapeutics to develop CNS drugs - BioWorld News","headline":"Cycle buying Applied Therapeutics to develop CNS drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQcTlISk1GTlFoUE1zYUJ4X1ZjdHg5bEY4NjBDU1BSenpySGQxTkk4VWNRYktlS19pbl91ZHRlRWE0dXVabGZCUDFEMGFxck9MLUY2WlUtMmNkdTBETFNSb05mTEhXclBJMXpRNWJObGNzWVhFTGVUQ0l6STd2WTRLMHZHTWF5VVRvYndHZTA5OXI1b2xZUmxGUFJ3d3hIUms4azdZWlRsTGF2UkV4Y2ROdVB2bkNZQVRaMVhSY1g2aUVxZFU?oc=5","date":"2025-12-11","type":"deal","source":"GlobeNewswire","summary":"Cycle Pharmaceuticals to Acquire Applied Therapeutics - GlobeNewswire","headline":"Cycle Pharmaceuticals to Acquire Applied Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQNnRqWmtFVmRRUXl6T0JienR0dzItbXlqd2RFSTdIMVBUdDNoZDYxNUQ2MkhPc1ZQZExxbzdEU1JSQ3luUnZnVFRlVmxDODc1aEd0UFRBbHBjYzV3YzJSTFAzX1ZKa2tiT29OeEJ1YkNFemhlSG8zVzYzb3ZONE5jMWxJS05LZ2MzRzdxalN4Zmd1cXRGQUhLZnNuQQ?oc=5","date":"2025-12-11","type":"earnings","source":"Stock Titan","summary":"Cycle to buy Applied Therapeutics (Nasdaq: APLT) in cash, CVR deal closing in Q1 2026 - Stock Titan","headline":"Cycle to buy Applied Therapeutics (Nasdaq: APLT) in cash, CVR deal closing in Q1 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQVUI5N2I2ZkdwWU5aR3otVjg4U1Z5QWpSOVVxNVU4SUhndXRoNlpVZGdFRnhaMXpza0o1ZGM1QmVZMjlZVVVYQW9LYUpGVVQ2eE1KajBSckdSN21lNzRuZHVSaE0zSVZZTWQwTFVnRThBWjREX3o0X3M4elpZSDU5UzBvQWMxbEZNM2o2dE5fdVJqZ0VG?oc=5","date":"2025-12-11","type":"pipeline","source":"Seeking Alpha","summary":"Cycle Pharmaceuticals acquiring Applied Therapeutics - Seeking Alpha","headline":"Cycle Pharmaceuticals acquiring Applied Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNRHlmU3I2NXBBaDNmbkFLR0Jvemk4UktYeC1Rc3F2N2NuOFdDN1V6SXoxeTlySHF1NmgtOERfNFg4ZjBhbUNRWENsV2lQOVZZbHdUYkhZX20zRVRKVGkxSGY3dnAzRVBidFJibHNGSkJrbEpwT25Cd1dQYmV0Q1FYU0twekdReVRpU2JESHhLNHJLRExFZl9Z?oc=5","date":"2025-11-13","type":"earnings","source":"Investing News Network","summary":"Applied Therapeutics Reports Third Quarter 2025 Financial Results - Investing News Network","headline":"Applied Therapeutics Reports Third Quarter 2025 Financial Results","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":455000,"revenuePeriod":"2024-12-31","revenueHistory":[{"value":455000,"period":"2024-12-31"},{"value":9993000,"period":"2023-12-31"},{"value":9993000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":48744000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-105624000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":86691000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}